[1]
“Severe Hypoalbuminemia Increases the Risk of Thrombocytopenia in Critically Ill Adult Patients Receiving Teicoplanin”, Dhaka Univ. J. Pharm. Sci, vol. 18, no. 2, pp. 153–157, Sep. 2019, doi: 10.3329/dujps.v18i2.43257.